Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The objectives of this study are:
- To evaluate the efficacy of Nyxol to improve mesopic low contrast visual acuity (mLCVA)
in subjects with Dim Light Vision Disturbances (DLD)
- To evaluate efficacy of Nyxol to improve visual performance
- To evaluate the safety of Nyxol